Volume 141, Issue 3, Pages (September 2011)

Slides:



Advertisements
Similar presentations
The new discoveries of Basic Researchers: bile acids, oxygen radicals, intestinal glucose metabolism reprogramming, others? Gilles Mithieux « Nutrition.
Advertisements

Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in Rats Adam P. Chambers, Lene Jessen, Karen.
Volume 6, Issue 4, Pages (April 2017)
Volume 5, Issue 10, Pages (October 2016)
Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1
Comparison of the effect by which gastric plication and sleeve gastrectomy procedures alter metabolic and physical parameters in an obese type 2 diabetes.
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Volume 150, Issue 2, Pages e9 (February 2016)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 10, Issue 2, Pages (August 2009)
Volume 8, Issue 3, Pages (September 2008)
David Bradley, Faidon Magkos, Samuel Klein  Gastroenterology 
Volume 141, Issue 5, Pages (November 2011)
Volume 126, Issue 3, Pages (March 2004)
Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1
Volume 143, Issue 2, Pages e2 (August 2012)
An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis  Laurie L. Baggio, Qingling Huang,
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 138, Issue 4, Pages (April 2010)
Substance P as a Novel Anti-obesity Target
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Outcomes Among Living Liver Donors
The Role of Gut Adaptation in the Potent Effects of Multiple Bariatric Surgeries on Obesity and Diabetes  Randy J. Seeley, Adam P. Chambers, Darleen A.
Volume 144, Issue 3, Pages e7 (March 2013)
Gastric Bypass Increases Energy Expenditure in Rats
Volume 137, Issue 3, Pages (September 2009)
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 138, Issue 7, Pages e3 (June 2010)
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice
Volume 142, Issue 4, Pages e3 (April 2012)
Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.
Volume 142, Issue 5, Pages e1 (May 2012)
Volume 155, Issue 2, Pages (August 2018)
Volume 13, Issue 8, Pages (November 2015)
Volume 131, Issue 6, Pages (December 2006)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Central Nervous System Mechanisms Linking the Consumption of Palatable High-Fat Diets to the Defense of Greater Adiposity  Karen K. Ryan, Stephen C. Woods,
Volume 150, Issue 2, Pages (February 2016)
Volume 141, Issue 3, Pages e4 (September 2011)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 10, Issue 2, Pages (August 2009)
This Month in Gastroenterology
Volume 138, Issue 5, Pages (May 2010)
Metabolic comparison of one-anastomosis gastric bypass, single-anastomosis duodenal-switch, Roux-en-Y gastric bypass, and vertical sleeve gastrectomy.
Dynamic fluid shifts induced by fetal bypass
Marzieh Salehi, Amalia Gastaldelli, David A. D'Alessio 
Volume 139, Issue 2, Pages (August 2010)
Body weight and oral glucose tolerance in diet-induced obese rats at 5 weeks post-surgery. Body weight and oral glucose tolerance in diet-induced obese.
Covering the Cover Gastroenterology
Volume 22, Issue 6, Pages (February 2018)
Postprandial Uridine Physiology Is Altered by Obesity
Volume 138, Issue 3, Pages e3 (March 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Volume 10, Issue 1, Pages (July 2009)
Volume 144, Issue 1, Pages e5 (January 2013)
Volume 9, Issue 1, Pages (January 2009)
Volume 22, Issue 2, Pages (August 2015)
Volume 156, Issue 6, Pages e1 (May 2019)
Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects  Kevin M. Korenblat, Elisa.
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 27, Issue 11, Pages e3 (June 2019)
Volume 4, Issue 5, Pages (November 2006)
The effect of VSG on body weight and body fat in GLP-1r KO mice.
Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.
Metabolic effects of VSG in GLP-1r KO mice.
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Volume 26, Issue 2, Pages e3 (January 2019)
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Presentation transcript:

Volume 141, Issue 3, Pages 950-958 (September 2011) Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in Rats  Adam P. Chambers, Lene Jessen, Karen K. Ryan, Stephanie Sisley, Hilary E. Wilson–Pérez, Margaret A. Stefater, Shrawan G. Gaitonde, Joyce E. Sorrell, Mouhamadoul Toure, Jose Berger, David A. D'Alessio, Stephen C. Woods, Randy J. Seeley, Darleen A. Sandoval  Gastroenterology  Volume 141, Issue 3, Pages 950-958 (September 2011) DOI: 10.1053/j.gastro.2011.05.050 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 (A) Cumulative food intake in sham (n = 10), RYGB (n = 4), VSG (n = 7), and pair-fed (n = 10) rats after 120 days. Average cumulative food intake was significantly higher in sham-operated rats vs RYGB, VSG, and pair-fed animals (P < .05). (B) Body weight was also significantly higher in sham rats compared to the other treatment groups (P < .05). (C) Lean tissue mass was slightly higher in sham-operated rats vs RYGB rats after 28 days (P < .05) and slightly higher than in VSG rats after 105 days (P < .05). (D) Fat tissue mass was substantially higher in sham vs all other treatment groups at 28 days (P < .05) and 105 days (P < .05) after surgery. Bonferroni's post-test; *P < .05 vs pair-fed; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 IP insulin sensitivity (A, B) and glucose tolerance (C, D) are improved in proportion to weight loss after RYGB and VSG procedures. (A) Blood glucose levels before (time 0) and after an IP injection of insulin in sham (n = 10), RYGB (n = 4), VSG (n = 7), and pair-fed rats (n = 10). RYGB, VSG, and pair-fed rats were more sensitive to effect of insulin on circulating glucose levels than ad lib–fed sham rats (P < .05). (B) The same data expressed as a percentage of baseline shows that changes in insulin sensitivity were not due to differences in basal circulating glucose. (C) Blood glucose levels before (time 0) and after an IP injection of glucose show that RYGB, VSG, and pair-fed rats also had lower glucose excursions and (D) plasma insulin levels relative to sham-operated rats in response to peripherally administered glucose. Bonferroni's post-test; *P < .05 vs pair-fed; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Whole body insulin sensitivity as measured by hyperinsulinemic euglycemic clamp. Average glucose infusion rate in sham (n = 8), RYGB (n = 7), VSG (n = 6), and pair-fed (n = 7) rats during steady state (final 40 min) clamp conditions. Glucose infusion rates were significantly increased in RYGB and VSG vs ad lib–fed sham rats (P < .05). Differences between RYGB, VSG, and pair-fed rats were nonsignificant (P > .05). Bonferroni's post-test; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 (A) Endogenous glucose production during hyperinsulinemic euglycemic was similar at baseline between sham (n = 8), RYGB (n = 7), VSG (n = 6), and pair-fed (n = 7) rats (P > .05). However, during steady-state conditions, glucose production was significantly reduced in RYGB and VSG rats vs sham and pair-fed rats (P < .05). (B) Glucose clearance was similar between treatments at baseline and during the final 40 minutes of the clamp (P > .05). Bonferroni's post-test; *P < .05 vs pair-fed; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 Active levels of the incretin hormone GLP-1(7-36) before (time 0) and after an oral gavage of Ensure Plus liquid diet in sham (n = 8), RYGB (n = 6), VSG (n = 6), and pair-fed (n = 9) rats. Postprandial plasma levels of GLP-1(7-36) were significantly higher in RYGB and VSG rats relative to sham and pair-fed animals (15, 30, and 45 min) (P < .05). RYGB rats also had significantly higher GLP-1(7-36) relative to pair-fed rats after 60 minutes. Differences between sham and pair-fed rats were not significant (P > .05). Bonferroni's post-test; *P < .05 vs pair-fed; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 Blood glucose (A, B) and plasma insulin (C, D) levels before (time 0) and after an oral gavage of Ensure Plus liquid diet in sham (n = 8), RYGB (n = 6), VSG (n = 6), and pair-fed (n = 9) rats. (A) Blood glucose levels were significantly lower in RYGB and VSG rats relative to ad lib–fed sham animals at 45 and 60 minutes (P < .05). (B) Differences in oral glucose tolerance were not significant between treatments when the data were expressed as area under the curve (P > .05). (C) Plasma insulin levels were significantly lower at baseline in RYGB and VSG rats relative to ad lib–fed sham animals (P < .05). Pair-feeding reduced plasma insulin levels relative to ad lib–fed sham rats at 15, 30, and 60 minutes (P < .05). (D) Insulin excursions expressed as a percentage of baseline showed that RYGB and VSG produced similar increases in postprandial insulin release that were not seen in pair-fed animals. Bonferroni's post-test; *P < .05 vs pair-fed; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 Blood glucose (A, B) and plasma insulin (C, D) levels before (time 0) and after an oral gavage of Ensure Plus liquid diet in rats pretreated with the GLP-1(7-36) receptor antagonist exendin(9-39). Sham (n = 8), RYGB (n = 6), VSG (n = 6), and pair-fed (n = 9) rats. (A) Area under the curve glucose was significantly lower in pair-fed vs VSG rats (P < .05). (B) Glucose excursions were significantly lower in pair-fed animals vs RYGB and VSG rats after 15 minutes (P < .05) and pair-fed vs ad lib–fed sham-operated rats after 60 minutes (P < .05). (C) Plasma insulin levels were not significantly different between treatments (P > .05). (D) Insulin levels expressed as a percentage of baseline were significantly higher in RYGB vs pair-fed and sham rats at 15 min (P < .05), but at no other time. *P < .05 vs pair-fed; $P < .05 vs RYGB; #P < .05 vs VSG. Gastroenterology 2011 141, 950-958DOI: (10.1053/j.gastro.2011.05.050) Copyright © 2011 AGA Institute Terms and Conditions